Filing Details
- Accession Number:
- 0001415889-22-009373
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-06 16:26:36
- Reporting Period:
- 2022-09-02
- Accepted Time:
- 2022-09-06 16:26:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750284 | Olema Pharmaceuticals Inc. | OLMA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1579397 | Charles William Shane Kovacs | C/O Olema Pharmaceuticals, Inc. 512 2Nd Street, 4Th Floor San Francisco CA 94107 | Ch. Operating & Financial Off. | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-02 | 20,000 | $0.00 | 381,197 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The weighted average purchase price for the transaction reported was $3.59, and the range of prices were between $3.53 and $3.60. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.
- Includes 2,517 shares acquired under the issuer's Employee Stock Purchase Plan.
Billionaire Hedge Funds
